Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Warts 1High-grade Anal Intraepithelial Neoplasia 1Carcinoma, Basal Cell 1

Interventions

Cryotherapy 11Salicylic Acid 3PRA1 protein, Candida albicans 3Cholecalciferol 3Cantharidin 3Tuberculin 2Solutions 2Sodium Chloride 2Saline Solution 2Percutaneous Collagen Induction 2Measles-Mumps-Rubella Vaccine 2Lasers 2Hydrogen Peroxide 2Human Papillomavirus Recombinant Vaccine nonavalent 2leupin 1lactic acid, salicylic acid drug combination 1green tea extract polyphenone E 1Zinc Sulfate 1Zinc 1Vitamin D 1Vaccination 1Trichloroacetic Acid 1Pyruvic Acid 1Photochemotherapy 1Methylene Blue 1Mass Screening 1Lasers, Solid-State 1Lasers, Gas 1Laser Therapy 1Ivermectin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Warts × green tea extract polyphenone E × Clear all
NCT02622568 2017-09-08

Investigating Veregen â„¢ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study

University of Texas Southwestern Medical Center

Phase 4 Completed
28 enrolled 7 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡